Phinomics logo — Decoding Circular DNA to Revolutionize Precision Medicine

Phinomics

Decoding Circular DNA to Revolutionize Precision Medicine

Founded 2020 United States San Carlos, United States 7 employees Seed Biotechnology, Health Care +3

General Information

Company Name Phinomics
Founded Year 2020
Location United States San Carlos, United States +1
Employees 7
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Seed
Social

Get notified when Phinomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Phinomics

Phinomics is a biotechnology startup established in 2020 with the goal of revolutionizing diagnostics and identifying new therapies. The company specializes in developing genome-based technologies to detect disorders and identify disease-specific genetic markers. The innovative approach of Phinomics focuses on identifying single-cell patterns in circular DNA, known as the Circulome™, to diagnose, prevent, and treat disorders associated with topological and genetic changes in DNA. Based in the United States, Phinomics operates within the Biotechnology and Health Care industries. The startup recently received a Seed Round investment on 27 May 2022 from Springboard Health Angels. With the support of this investment, Phinomics aims to further advance its pioneering technologies and expand its capabilities in the field of genomic diagnostics and personalized medicine. The company's ambitious slogan, "Solving the Circular-DNA Puzzle," reflects its commitment to addressing critical medical challenges through cutting-edge genetic insights and technologies.

Taxonomy: genome-based technologies, diagnostics, disease-specific genetic markers, circular DNA, single-cell patterns, Circulome, disorders, topological changes, genetic changes, DNA, genetic diagnostics, therapies, molecular diagnostics, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
27 May 2022

Phinomics Alternatives & Competitors

Phinomics vs

Advancing genomics for groundbreaking diagnostics and personalized treatments

Grant
12 employees
Biotechnology, Health Care
Phinomics vs

- Accredited with ISO 15189:2014 - Pioneer NIPT lab in Malaysia: NICC - Your Trusted Partner in Ge...

36 employees
Health Care
Phinomics vs

India's No1 Genetic DNA Testing laboratory

19 employees
Biotechnology, Health Care

FAQ About Phinomics

Decoding Circular DNA to Revolutionize Precision Medicine
Phinomics was founded in 2020.
Phinomics is headquartered in San Carlos, United States.
Phinomics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Clean Energy.
Phinomics has approximately 7 employees.
Phinomics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Phinomics include Scripps Research Translational Institute, DNA Laboratories Sdn Bhd, DNA LABS INDIA, MNM Diagnostics, Anchor Molecular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phinomics and Scripps Research Translational Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Phinomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy